Navigation Links
Scott & White Healthcare researchers studying investigational agent that targets breast cancer
Date:3/23/2010

Scott & White Healthcare researchers are studying an investigational agent that targets metastatic breast cancer to find if it can stop cancer cells from continuing to grow.

Breast cancer patients, whose disease has spread despite treatment, could be eligible to participate in a Phase II clinical trial to determine the efficacy of an investigational agent used to target the inner workings of cancer cells.

"At Scott & White, one of the things we can offer patients is our novel clinical trials," said Christopher O. Ruud, M.D., director of Scott & White's Breast Cancer Clinic. "By enrolling in this study, patients with metastatic breast cancer can help us learn what works in halting the growth of their cancer cells."

Dr. Ruud, along with Drs. Dan Hadlock, and Juan Posada of Scott & White, is involved in numerous studies targeting breast cancer. Their ultimate goal is to turn breast cancer into a manageable disease.

"Our goal is to help patients continue living a normal life," he said. "That is one of our strategies at Scott & White to find ways to treat breast cancer that has failed other treatments."


'/>"/>

Contact: Katherine Voss
kvoss@swmail.sw.org
254-724-4097
Scott & White Healthcare
Source:Eurekalert

Page: 1

Related medicine news :

1. Allergy Relief, Chiropractic and Biofeedback Provided at New Absolute Health Clinic in Scottsdale, Arizona
2. SUNZ Insurance Company Selects Scott Robertson as President
3. James Scott Farrin Supports Radiothon for Duke Children's Hospital
4. Scott & White Healthcare pathologist is co-investigator on breast cancer study
5. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
6. Trustmark and HealthFitness Announce Early Termination of Hart-Scott-Rodino Waiting Period
7. Scott Roeder Trial: Randall Terry, Operation Rescue Founder and Insurrecta Nex Members to Attend Trial in Wichita
8. New study shows TGen spin-off boosts Scottsdale economy
9. Let Us Mute Our Praise for Scott Brown - a "Moderate" Child-Killer - and Seek to Replace Him With a True Pro-Lifer in Two Years, Says Randall Terry
10. Scott & White Healthcare researching treatments for rare cancers
11. Julian Lennon and James Scott Cook Release New Charity Single LUCY to Raise Awareness and Funds for Lupus Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... Angeles, CA (PRWEB) , ... September 25, 2017 , ... ... of a full-time office in downtown Los Angeles, to service existing clients in the ... surrounding areas. , “We are seeing an ever-increasing amount of business demand west of ...
(Date:9/24/2017)... ... , ... Bhowanie Benimadhu’s new book “ Our Creative World: Our Created Life ... answers in both Eastern and Western religious traditions and spirituality such as Hinduism ... of humankind for the past thousands of years and still are,” Benimadhu says. “By ...
(Date:9/24/2017)... ... September 24, 2017 , ... The Tuscany Resort on Grace Bay in ... Provo's premier boutique resorts, is planning on re-opening the resort on October 1st. ... Irma and more recently Hurricane Maria, and the staff and landscaping crews were fast ...
(Date:9/24/2017)... ... ... “Star of Bethlehem Study”: is a thought-provoking essay focusing on the most ... Duane Engdahl, an investigator who had has a long and eventful career in science ... a thought-provoking essay an event so significant that it is referred to as the ...
(Date:9/23/2017)... ... 23, 2017 , ... “You Can't Win Them All”: the story of an ... and on the ice changed the lives of young athletes. “You Can't Win ... born and educated in Schreiber, a small town in Northern Ontario, Canada. He ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Sept. 6, 2017 Eli Lilly and Company ... present new data for galcanezumab and lasmiditan, two investigational ... International Headache Society (IHC) taking place Sept. 7-10 in ... will highlight new, long-term data from an open-label study ... galcanezumab (120 mg and 240 mg) for the prevention ...
(Date:9/5/2017)... 2017  Just 18 months after its February 2016 ... announce the appointment of three new senior people to ... Dominic Jones-Phillips and James Wright bring ... Tammy Wynne joins as ... writers. She has over ten years, experience in global ...
(Date:9/1/2017)... -- Bayer will present the latest research from across its growing ... 2017 Congress, September 8-12 in Madrid, Spain ... data on Bayer,s marketed portfolio and late-stage compounds as well ... "We value the opportunity to meet ... ESMO," said Carsten Brunn , Head of Pharmaceuticals, Americas ...
Breaking Medicine Technology: